Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole

Mycoses, EarlyView.

Source: Mycoses - August 13, 2018 Category: Research Authors: Johan Maertens , Dominik Selleslag , Werner J. Heinz , Mikael Saulay , Galia Rahav , Michael Giladi , Mickael Aoun , Laura Kovanda , Achim Kaufhold , Marc Engelhardt , Oliver A. Cornely , Raoul Herbrecht , Source Type: research